Charles River Laboratories | CRL - Market Capitalization


Charles River Laboratories reported $10.61B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 32.66B 5.2B Mar/2026
Align Technology USD 12.28B 1.07B Mar/2026
Bruker USD 5.5B 1.66B Mar/2026
Cardinal Health USD 49.72B 894M Mar/2026
Charles River Laboratories USD 7.85B 2.17B Mar/2026
Cigna USD 70.33B 3.19B Mar/2026
Concord Medical Services Hldg CNY 166.72M 11.49M Apr/2026
CVS Health USD 92.04B 8.7B Mar/2026
Danaher USD 128.46B 33.24B Mar/2026
Dentsply International USD 2.32B 36M Mar/2026
Elevance Health USD 64.31B 13.6B Mar/2026
Humana USD 20.82B 9.99B Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
Incyte USD 18.73B 660M Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 106B 4.75B Mar/2026
Merck EUR 46.78B 6.52B Mar/2026
Mettler Toledo International USD 25.54B 2.94B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Revvity USD 9.94B 1.03B Mar/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
UnitedHealth USD 245.61B 53.42B Mar/2026
Veradigm USD 525M 621M Mar/2026
Waters USD 29.87B 7.25B Mar/2026
West Pharmaceutical Services USD 18.07B 1.73B Mar/2026